기본 정보
- CAS
81267-65-4- 표준 SMILES
Oc1ccc(C2=Cc3ccc(O)cc3OC2)cc1- InChIKey
ZZUBHVMHNVYXRR-UHFFFAOYSA-N- 분자식
- C15H12O3
- 평균 분자량
- 240.25 g/mol
- 단동위원소 질량
- 240.07864424
개요
Idronoxil is a substance that is being studied in the treatment of cancer. It belongs to the family of drugs called signal transduction inhibitors.
이름 및 식별자
- 우선 이름
- Phenoxodiol
- IUPAC
- 3-(4-hydroxyphenyl)-2H-chromen-7-ol
- 현지명
- 페녹소디올
- 영어명
- Phenoxodiol
- 분자식
- C15H12O3
- 분자량
- 240.25
이름 및 동의어
PhenoxodiolIdronoxil81267-65-43-(4-Hydroxyphenyl)-2H-chromen-7-ol3-(4-Hydroxyphenyl)-2H-1-benzopyran-7-olNV-062H-1-Benzopyran-7-ol, 3-(4-hydroxyphenyl)-Idronoxilo7-hydroxy-3-hydroxyphenyl-1H-benzopyran995FT1W541DTXSID50231029idronoxilum
이름 더 보기
페녹소디올NV 06Idronoxil，PhenoxodiolPhenoxodiol, 10 mM in DMSO7,4'-DIHYDROXYISOFLAV-3-ENEPhenoxodiol Haginin E Idronoxil
2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)RefChem:790571NOX66DTXCID00153520663-523-9DehydroequolHaginin EPhenoxodiol (Haginin E)
데이터베이스 식별자
- CAS
81267-65-4- PubChem CID
- 219100
- DTXSID
DTXSID50231029- ChEMBL
CHEMBL1957038- UNII
- 995FT1W541
- EC Number
- 663-523-9
- Nikkaji
물성
구조 계산 물성
- XLogP
- 2.7
- 극성 표면적
- 49.7 Ų
- 수소 결합 공여자 수
- 2
- 수소 결합 수용자 수
- 3
- 회전 가능 결합 수
- 1
- 무거운 원자 수
- 18
- 형식 전하
- 0
- 복잡도
- 318
실험 및 물리화학적 성질
DrugsPharmaceuticals -> Listed in ZINC15
SpringerMaterials Properties13C nuclear magnetic resonance spectrum
Endocrine DisruptorsPotential endocrine disrupting compound
물리화학적 성질
- 저장 조건
- room temp
- 용해도
- 10 mg/mL, · DMSO: 용해성10mg/mL, 투명
- 물리적 상태
- 가루
- 색상
- 흰색에서 밝은 갈색까지
안전 및 규제
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
GHS 분류
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P273, P301+P317, P330, P391, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
유해성 정보
Hazard Classes and CategoriesAcute Tox. 4 (100%)
안전 데이터
- wgk
- 3
- ridadr
- UN 3077 9 / PGIII
- risk_code
- 22-50
- hazard_code
- Xn,N
- safety_code
- 61
화학 및 산업
약리 정보
Pharmacodynamics
Phenoxodiol inhibits proliferation of many cancer cell lines and induces apoptosis by disrupting FLICE-inhibitory protein, FLIP, expression and by caspase-dependent and -independent degradation of the X-linked inhibitor of apoptosis, XIAP. In addition, phenoxodiol sensitizes drug-resistant tumour cells to anticancer drugs including paclitaxel, carboplatin and gemcitabine.
Mechanism of Action
The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells. Results from one study (PMID: 17904534) indicate that plasma membrane electron transport (PMET) may be a primary target for phenoxodiol in tumour cells and in activated T cells.
응용 분야
용도Antineoplastic which acts as an antiproliferative, topoisomerase II inhibitor; 5 reductase inhibitor[Note— The trivial name, phenoxodiol, has appeared in literature].
공급사65 곳
陕西缔都医药有限责任公司029-81124775 17791530730 · [email protected]
Career Henan Chemica Co+86-0371-86658258 +86-13203830695 · [email protected]
武汉英诺医药科技有限公司+86-027-59232304 15387063101 · [email protected]
成都超九八生物科技有限公司13348960310 13348960310 · [email protected]
杭州摩库生物医药科技有限公司+86-057181025280; +8617767106207 · [email protected]
武汉众志诚生物技术有限公司13628624121 13628604890 · [email protected]
관련 반응
19건
화합물 노트
불러오는 중…